BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23894034)

  • 21. In silico methods for physiologically based biokinetic models describing bioactivation and detoxification of coumarin and estragole: implications for risk assessment.
    Rietjens IM; Punt A; Schilter B; Scholz G; Delatour T; van Bladeren PJ
    Mol Nutr Food Res; 2010 Feb; 54(2):195-207. PubMed ID: 19943261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiologically based biokinetic (PBBK) modeling of safrole bioactivation and detoxification in humans as compared with rats.
    Martati E; Boersma MG; Spenkelink A; Khadka DB; van Bladeren PJ; Rietjens IM; Punt A
    Toxicol Sci; 2012 Aug; 128(2):301-16. PubMed ID: 22588462
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tandem mass spectrometry analysis of N2-(trans-Isoestragol-3'-yl)-2'-deoxyguanosine as a strategy to study species differences in sulfotransferase conversion of the proximate carcinogen 1'-hydroxyestragole.
    Punt A; Delatour T; Scholz G; Schilter B; van Bladeren PJ; Rietjens IM
    Chem Res Toxicol; 2007 Jul; 20(7):991-8. PubMed ID: 17590023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vivo genotoxicity of estragole in male F344 rats.
    Ding W; Levy DD; Bishop ME; Pearce MG; Davis KJ; Jeffrey AM; Duan JD; Williams GM; White GA; Lyn-Cook LE; Manjanatha MG
    Environ Mol Mutagen; 2015 May; 56(4):356-65. PubMed ID: 25361439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection and quantification of specific DNA adducts by liquid chromatography-tandem mass spectrometry in the livers of rats given estragole at the carcinogenic dose.
    Ishii Y; Suzuki Y; Hibi D; Jin M; Fukuhara K; Umemura T; Nishikawa A
    Chem Res Toxicol; 2011 Apr; 24(4):532-41. PubMed ID: 21384859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular levels and molecular dynamics simulations of estragole DNA adducts point at inefficient repair resulting from limited distortion of the double-stranded DNA helix.
    Yang S; Diem M; Liu JDH; Wesseling S; Vervoort J; Oostenbrink C; Rietjens IMCM
    Arch Toxicol; 2020 Apr; 94(4):1349-1365. PubMed ID: 32185416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex differences in the activation of tamoxifen to DNA binding species in rat liver in vivo and in rat hepatocytes in vitro: role of sulfotransferase induction.
    Davis W; Hewer A; Rajkowski KM; Meinl W; Glatt H; Phillips DH
    Cancer Res; 2000 Jun; 60(11):2887-91. PubMed ID: 10850433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of human interindividual variation in bioactivation of estragole using physiologically based biokinetic modeling.
    Punt A; Jeurissen SM; Boersma MG; Delatour T; Scholz G; Schilter B; van Bladeren PJ; Rietjens IM
    Toxicol Sci; 2010 Feb; 113(2):337-48. PubMed ID: 19920071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patterns of DNA adduct formation in liver and mammary epithelial cells of rats treated with 7,12-dimethylbenz(a)anthracene, and selective effects of chemopreventive agents.
    Izzotti A; Camoirano A; Cartiglia C; Grubbs CJ; Lubet RA; Kelloff GJ; De Flora S
    Cancer Res; 1999 Sep; 59(17):4285-90. PubMed ID: 10485473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of allylbenzene 2',3'-oxide and estragole 2',3'-oxide in the isolated perfused rat liver.
    Luo G; Guenthner TM
    J Pharmacol Exp Ther; 1995 Feb; 272(2):588-96. PubMed ID: 7853172
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steroidal drug cyproterone acetate is activated to DNA-binding metabolites by sulfonation.
    Werner S; Kunz S; Wolff T; Schwarz LR
    Cancer Res; 1996 Oct; 56(19):4391-7. PubMed ID: 8813132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Influence of Cultivars and Phenological Phases on the Accumulation of Nevadensin and Salvigenin in Basil (Ocimum basilicum).
    Bernhardt B; Bernáth J; Gere A; Kókai Z; Komáromi B; Tavaszi-Sárosi S; Varga L; Sipos L; Szabó K
    Nat Prod Commun; 2015 Oct; 10(10):1699-702. PubMed ID: 26669105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioactivation of estragole and anethole leads to common adducts in DNA and hemoglobin.
    Bergau N; Herfurth UM; Sachse B; Abraham K; Monien BH
    Food Chem Toxicol; 2021 Jul; 153():112253. PubMed ID: 34015424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of hepatocarcinogenicity of estragole on the glucocorticoid-mediated induction of liver-specific enzymes and the activity of the transcription factors FOXA and HNF4 in the liver of mouse and rat].
    Kaledin VI; Pakharukova MIu; Pivovarova EN; Kropachev KIu; Baginskaia NV; Vasil'eva ED; Il'nitskaia SI; Nikitenko EV; Kobzev VF; Merkulova TI
    Biofizika; 2010; 55(2):326-35. PubMed ID: 20429289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The formation and persistence of carboplatin-DNA adducts in rats.
    Blommaert FA; Michael C; van Dijk-Knijnenburg HC; Schornagel JH; den Engelse L; Fichtinger-Schepman AM
    Cancer Chemother Pharmacol; 1996; 38(3):273-80. PubMed ID: 8646803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible involvement of genotoxic mechanisms in estragole-induced hepatocarcinogenesis in rats.
    Suzuki Y; Umemura T; Hibi D; Inoue T; Jin M; Ishii Y; Sakai H; Nohmi T; Yanai T; Nishikawa A; Ogawa K
    Arch Toxicol; 2012 Oct; 86(10):1593-601. PubMed ID: 22576464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiologically based kinetic models for the alkenylbenzene elemicin in rat and human and possible implications for risk assessment.
    van den Berg SJ; Punt A; Soffers AE; Vervoort J; Ngeleja S; Spenkelink B; Rietjens IM
    Chem Res Toxicol; 2012 Nov; 25(11):2352-67. PubMed ID: 22992039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DNA adduct formation and T lymphocyte mutation induction in F344 rats implanted with tumorigenic doses of 1,6-dinitropyrene.
    Beland FA
    Res Rep Health Eff Inst; 1995 Oct; (72):1-27; discussion 29-39. PubMed ID: 11381742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A physiologically based in silico model for trans-2-hexenal detoxification and DNA adduct formation in rat.
    Kiwamoto R; Rietjens IM; Punt A
    Chem Res Toxicol; 2012 Dec; 25(12):2630-41. PubMed ID: 22978292
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.